SCHEMBL29618403

SCHEMBL29618403

N#Cc1cc2c(nc1Cl)CCO2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.53
KDM4E B2RXH2 3/20 0.43
GAA P10253 2/20 0.43
PKM P14618 2/20 0.42
POLB P06746 1/20 0.41
KHK P50053 1/20 0.40
ALDH1A1 P00352 4/20 0.37
MAPK1 P28482 2/20 0.37
NSD2 O96028 1/20 0.37
NPSR1 Q6W5P4 4/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
CASP1 P29466 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28758443 1.00 SMN1; SMN2 (0.53) SMN1; SMN2KDM4EGAAPKMPOLB
SCHEMBL24517473 0.80 KDM4E (0.40) SMN1; SMN2KDM4EGAAPKMKHK
SCHEMBL29618324 0.80 KDM4E (0.40) SMN1; SMN2KDM4EGAAPKMKHK
SCHEMBL24517534 0.80 KDM4E (0.36) SMN1; SMN2KDM4EGAAPKMPOLB
SCHEMBL22089493 0.78 SMN1; SMN2 (0.48) SMN1; SMN2KDM4EGAAPKMPOLB
SCHEMBL30711985 0.75 SMN1; SMN2 (0.64) SMN1; SMN2KDM4EGAAPKMPOLB
SCHEMBL845573 0.75 SMN1; SMN2 (0.64) SMN1; SMN2KDM4EGAAPKMPOLB
SCHEMBL16372681 0.72 NPC1 (0.58) SMN1; SMN2KDM4EGAAPKMPOLB
SCHEMBL5624979 0.69 SMN1; SMN2 (1.00) SMN1; SMN2KDM4EGAAALDH1A1MAPK1
SCHEMBL16019318 0.69 SMN1; SMN2 (0.93) SMN1; SMN2KDM4EGAAPKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022121805-A1 FUSED RING COMPOUND AS NAV1.8 INHIBITOR AND USE THEREOF 成都康弘药业集团股份有限公司 2022-06-16 WO disclosed
CN-114591293-A Fused ring compound as Nav1.8 inhibitor and application thereof 成都康弘药业集团股份有限公司 2022-06-07 CN disclosed